Point72 Hong Kong LTD Neogenomics Inc Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $86,562 - $171,286	12,261 New	12,261 $100,000
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $11,248 - $14,180	-270 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $9,887 - $13,956	270 New	270 $12,000
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $35,159 - $50,658	-846 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $30,523 - $47,773	846 New	846 $46,000
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $1,099 - $1,730	-58 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $1,108 - $1,521	58 New	58 $1,000
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $87,203 - $107,389	-4,456 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $50,393 - $84,929	4,151 Added 1360.98%	4,456 $91,000
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $4,619 - $7,603	-411 Reduced 57.4%	305 $4,000
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $8,950 - $11,012	716 New	716 $11,000

281

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.